Epigenetic formatting of satiety gene may increase risk of obesity in women

Eli Lil­ly is bol­ster­ing the case for its ex­per­i­men­tal eczema treat­ment le­brik­izum­ab with a first look at how pa­tients fared af­ter two years of main­te­nance

Neu­rol­o­gists who were asked about new treat­ments for amy­otroph­ic lat­er­al scle­ro­sis (ALS) say they val­ue ef­fi­ca­cy and qual­i­ty-of-life im­prove­ments over safe­ty for drugs in de­vel­op­ment.